We aim to continually create new gene and cell therapy modalities by developing platform technology for biologics discovery through our business that support life science research. Koichi Nakao President Learn more

Our website uses cookies to ensure that we give you the best user experience.Read more
By continuing to use our site, you consent to our cookies.